News | Cardiovascular Clinical Studies | July 12, 2022

Mask Wearing Amplifies Harms of Smoking

Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold rise in exhaled carbon monoxide and impaired blood vessel function compared to non-mask periods

Getty Images 


July 11, 2022 — Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold rise in exhaled carbon monoxide and impaired blood vessel function compared to non-mask periods. That’s the finding of research published in the European Journal of Preventive Cardiology, a journal of the ESC.1

“The study suggests that smoking any tobacco product has become even more hazardous during the COVID-19 pandemic because of the need to wear a mask for long hours,” said study author Professor Ignatios Ikonomidis of the National and Kapodistrian University of Athens, Greece. “Prior research has shown that impaired vascular function is linked with heart problems and premature death.”

The study focused on traditional (combustible) cigarettes and non-combustible cigarettes, also called “heat not burn” or “heated” tobacco products. Non-combustible cigarettes contain tobacco which is electronically heated to a lower temperature than a combusted cigarette, delivering an inhalable aerosol containing nicotine. The study did not include e-cigarettes (also called vaping) which electronically heat a liquid containing nicotine to create an aerosol that is inhaled.
The researchers investigated the levels of exhaled carbon monoxide in smokers while wearing a mask during working hours and compared it to carbon monoxide levels during days off without a mask. In a second step, the researchers examined whether the change in carbon monoxide exposure was accompanied by impaired blood vessel function.
The study included 40 smokers of conventional cigarettes, 40 exclusive heat not burn cigarette users and 40 non-smokers with similar age and sex who were medical personnel in a university hospital. Individuals with known cardiovascular disease, hypertension, diabetes, dyslipidaemia, chronic kidney disease or atrial fibrillation were excluded as these conditions may affect vascular function.
The researchers measured exhaled carbon monoxide after a deep breath and markers of vascular function (pulse wave velocity, augmentation index and central systolic blood pressure). Baseline assessments were done early in the morning after sleeping without a mask to obtain values after a long period without smoking. Participants were randomised to a second assessment after either an eight hour shift wearing a mask or eight hours off without a mask. They then crossed over to a third assessment after either eight hours off with no mask or eight hour working with a mask.
The average age of participants was 45 years and 72% were women. A similar number of combustible or non-combustible cigarettes were smoked during mask and non-mask periods. In conventional cigarette smokers, exhaled carbon monoxide increased from 8.00 parts per million (ppm) at baseline to 12.15 ppm with no mask and 17.45 ppm with a mask. In non-combustible cigarette smokers, exhaled carbon monoxide increased from 1.15 ppm at baseline to 1.43 ppm with no mask and 2.20 ppm with a mask. Among non-smokers, exhaled carbon monoxide did not differ between the baseline, non-mask and mask periods.
In both combustible and non-combustible cigarette smokers, all vascular markers were higher while wearing a mask compared to no mask. In non-smokers, there were no differences in vascular markers between the three periods.
Professor Ikonomidis said: “Compared to smokers of combustible cigarettes, non-combustible cigarette users had lower baseline carbon monoxide levels and smaller increases in vascular damage while wearing a mask. Nevertheless, the findings show that smoking any tobacco product while wearing a mask may further impair blood vessel function compared to non-mask periods, at least partly due to greater re-inhalation of carbon monoxide and/or vapour rich in nicotine. The results provide even more impetus for all smokers to kick the habit.” 

For more information: https://www.escardio.org/ 

Find more content from ESC22

Reference

1Ikonomidis I, Katogiannis K, Kourea K, et al. The effect of smoking on exhaled carbon monoxide and arterial elasticity during prolonged surgical mask use in the COVID-19 era. Eur J Prev Cardiol. 2022. doi:10.1093/eurjpc/zwac101.
Link will go live on publication:
https://academic.oup.com/eurjpc/article-lookup/doi/10.1093/eurjpc/zwac101 

Related Content

News | ESC

Organizers of the European Society of Cardiology (ESC) Congress have released plans and announced 10 Hot Line Sessions ...

Home July 22, 2022
Home
News | ESC

June 1, 2022 — Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease ...

Home June 01, 2022
Home
News | ESC

May 9, 2022 — Heart failure presents differently in women and men – discover the latest evidence and its impact on ...

Home May 09, 2022
Home
News | ESC

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...

Home March 31, 2022
Home
News | ESC

January 3, 2022 — The following is a list of the 2021 news stories from the European Society of Cardiology (ESC) ...

Home January 03, 2022
Home
News | ESC | By Dave Fornell, DAIC Editor

October 4, 2021 — Here are links to all the late-breaking cardiology studies presented in Hot-Line sessions at the 2021 ...

Home October 04, 2021
Home
News | ESC

The European Society of Cardiology (ESC) will host several Hot Lines sessions that will include some of the latest ...

Home July 21, 2020
Home
News | ESC

May 6, 2020 — The European Society of Cardiology (ESC), one of the world's largest cardiovascular conferences, is ...

Home May 06, 2020
Home
Feature | ESC

September 9, 2019 — More than 33,000 health professionals gathered over five days to attend the 2019 European Society of ...

Home September 09, 2019
Home
News | ESC

September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...

Home September 12, 2017
Home
Subscribe Now